Century Therapeutics, Inc. — Director's Dealing 2024

Jun 10, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Century Therapeutics, Inc. (IPSC)
CIK: 0001850119
Period of Report: 2024-06-07

Reporting Person: Carr Douglas (SVP Finance & Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-07	Common Stock	A	17007	—	Acquired	334330	Direct

Footnotes

F1: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs vest 100% on June 7, 2025, subject the Reporting Person's continued service through such vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.